key: cord-0985635-i4v5irca
authors: Iyengar-Kapugati, Rupa L.; Patel, Neil; Anastasius, Malcolm; She, Trent; Nelson, Bret P.; Murphy, Megan; Kukar, Nina; Miller, Michael; Doo, Florence; Argulian, Edgar; Kini, Annapoorna; Lerakis, Stamatios
title: Point of Care Ultrasound findings and clinical outcomes in COVID-19 patients
date: 2020-08-18
journal: J Am Soc Echocardiogr
DOI: 10.1016/j.echo.2020.08.014
sha: d13439da271416a1f545addf3acfa4e7db9914f3
doc_id: 985635
cord_uid: i4v5irca

nan

Point of care ultrasound (POCUS) has been increasingly used for efficient detection of cardio-respiratory COVID-19 infection complications. 1 Cardiac POCUS may have similar benefits to transthoracic echocardiography while decreasing staff exposure to patients with COVID-19 infection. Cardiac POCUS has utility 1 , with up to 50% of patients with COVID-19 infection having cardiac abnormalities on echocardiography, that leads to management changes in nearly one-third. 2 POCUS of the lung enables diagnosis of pathologies such as alveolar consolidation, and alveolar-interstitial syndrome. The relationship between POCUS findings and COVID-19 infection outcomes is unknown. The study aim was to identify how lung and cardiac POCUS findings in COVID-19 patients relate to clinical outcomes.

We retrospectively reviewed lung and cardiac POCUS performed in patients with COVID-19 infection and suspected cardio-respiratory involvement, at the time of presentation to NY hospitals between 04/01/20-05/15/20. POCUS was performed by certified ER physicians. Lung POCUS was used to identify the presence of A-and B-Lines (Table) . Cardiac POCUS was performed according to ASE recommendations. 3 The study cohort was divided into those who did (Group 1) and did not (Group 2) develop the primary outcome of death or need for mechanical ventilation.

Patients in Group 1 were older [73 (58-59) vs. 62 (52-73), p=0.004], however CVD risk factors were similar between the groups. All lung POCUS exams were interpretable. Amongst cardiac POCUS studies, 99% and 88% had suitable imaging for LV and RV assessment respectively. Lung POCUS findings in the two patient groups did not differ, with B-lines being prevalent in both groups. Lung POCUS has limitations in COVID-19 and may not detect centrally located consolidation from bacterial super infection.

With cardiac POCUS, Group 1 patients had a higher incidence of reduced LVEF (37.9% vs. 16.2% respectively, p=0.045). Sud et al showed that acute LV systolic dysfunction was present in approximately 20% of acutely ill COVID-19 patients and was due to myocarditis, stress-induced cardiomyopathy, or coronary thrombosis. 4 In the present study, it is possible that patients had pre-existing LV dysfunction, unrelated to COVID-19. Cardiac POCUS J o u r n a l P r e -p r o o f has a critical role in management of patients with COVID-19. Our study showed that cardiac POCUS may risk stratify acutely ill patients with COVID-19 infection, based upon LV function, and identify cohorts with pre-existing or new LV dysfunction that are at higher risk of adverse outcomes. The incidence of abnormal RV findings was lower than in prior studies 4 

Bedside Focused Cardiac Ultrasound in COVID-19 from the Wuhan Epicenter: The Role of Cardiac Point-of-Care Ultrasound, Limited Transthoracic Echocardiography, and Critical Care Echocardiography

Global evaluation of echocardiography in patients with COVID-19

Recommendations for Echocardiography Laboratories Participating in Cardiac Point of Care Cardiac Ultrasound (POCUS) and Critical Care Echocardiography Training: Report from the American Society of Echocardiography

Echocardiographic Findings in Patients with COVID-19 with Significant Myocardial Injury

ASE statement on Point-of-Care Ultrasound (POCUS) During the 2019 Noval Coronavirus Pandemic